Bioventus(BVS)
DURHAM, NCBiotechnology
Focus: Bioventus is a public orthobiologics company focused on musculoskeletal solutions including hyaluronic acid injectables, ultrasound-based bone healing devices, and neuromodulation systems. With ~$512M in annual revenue and 1,001-5,000 employees, it operates at the mid-cap biotech scale.
Profile data last refreshed 36m ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
0
About Bioventus
AI assessmentNot HiringNo open roles listed right now. Follow Bioventus to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Bioventus's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Early-stage
17 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$512M
Pipeline & Clinical Trials
Durolane
OsteoarthritisClinical Trials (1)
NCT02610504Prospective Single Center Open Label Study of Shoulder OA Pain
N/AHelp build intelligence for Bioventus
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.